Abstract
N/A
Highlights
FC21 Poster, Med Learning Group, CME supported by educational grants from Regeneron Pharmaceuticals, Inc and Sano Genzyme
Overall 29% increase in knowledge of immune escape mechanisms and how they contribute to pathogenesis of BCC and cSCC
Ability to identify patients with BCC and cSCC who can benefit from immunotherapy utilizing tumor staging, risk stratification, and guidelines
Summary
Completers Indicated That Interactive Tools Enhanced Their Learning and Improved Recall indicated the VR, infographics, and. View BCC animation: Personalized Posters Were Effective Reference Resources & Patient Education Tools. Reported using reported using in discussions in discussions with patients with colleagues. Overall 29% increase in knowledge of immune escape mechanisms and how they contribute to pathogenesis of BCC and cSCC
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
